Comparison of Therapeutic Efficacy Between Lobeglitazone and Pioglitazone as Initial Triple Therapy With Metformin and Sitagliptin in Drug-naïve Type 2 Diabetic Patients
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Lobeglitazone (Primary) ; Metformin; Pioglitazone; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Jun 2017 Results (n=85) presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 10 Jun 2017 Biomarkers information updated
- 25 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2017.